Project Zero Delay Accelerates Drug's Path to Clinical Trial
... reported their work in the Journal of Clinical
oncology published online on August 3(rd).
The ... said Alan Barge, vice president and Head of
oncology at AstraZeneca. "AZ is always looking to improve ... cardiovascular, neuroscience, respiratory,
oncology and infectious disease medicines. For more ...
Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
... Subar, National Practice Leader for Medco's
oncology Therapeutic Resource Center located at Medco's ... Meeting of the American Society of Clinical
oncology (ASCO). It was the largest study to-date looking ... the Medco Therapeutic Resource Center (TRC) for
oncology patients. Medco's TRCs focus on the specialized ...
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
... pipeline, bringing the company's total number of
oncology molecules in clinical development to 23 and the ... antibodies contributed by ImClone to the Lilly
oncology portfolio is a great step toward achievement of the
oncology powerhouse we are building. Our new location in ...
UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201
...
US
oncology Research Network Participates in Phase III ... US Oncology, Inc . today announced that US
oncology Research will participate in the BiPar ... Joyce O'Shaughnessy, M.D. , co-chair of the US
oncology Breast Cancer Research Committee, associate ...
Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
... almost 20,000 patient records from the Southwest
oncology Group's database of clinical trials finds, for ... That study, published in the Journal of Clinical
oncology , analyzed data on 634 breast cancer patients.
... of its data," says Joseph Unger of the Southwest
oncology Group's Statistical Center, who was statistician ...
Gene Findings Unlocking Reasons for Neuroblastoma Risk
... said study leader John M. Maris, M.D., chief of
oncology and director of the Cancer Center at The ... from around the world through the Children's
oncology Group.
The BARD1 gene had already attracted attention from
oncology researchers because it is associated with the ...
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
... patient population but we remain committed to
oncology clinical research and developing innovative ... disorders.
About Cephalon
oncology
Cephalon, a leading biopharmaceutical company, is building a diversified portfolio of
oncology products that represents a comprehensive approach ...
Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options
... were presented at American Society of Clinical
oncology (ASCO) 2009 Annual Meeting on June 1, 2009 is now ... which are handpicked by leading experts in
oncology and hematology for the Clinical Care Options ... to developing an integrated portfolio of
oncology products aimed at making cancer more treatable. ...
Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
... at the 2009 American Society for Clinical
oncology (ASCO) Annual Meeting, patients with cancer of ... 707-12 (2003)).
The Brown University
oncology Group lead by Dr. Howard Safran published ... to developing an integrated portfolio of
oncology products aimed at making cancer more treatable. ...
Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
... Presented at American Society of Clinical
oncology 2009 Annual Meeting and Included in Best of ... of the trial and chief of the Genitourinary
oncology Service and the D. Wayne Calloway Chair in Urologic
oncology at Memorial Sloan-Kettering Cancer Center in New ...
Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
... today at the 2009 American Society of Clinical
oncology (ASCO) Annual Meeting in Orlando, Fl.
Three ... clinical studies, we are eager to work with the
oncology and pathology communities to integrate molecular ... bioTheranostics provides innovative tests to the
oncology community that help drive personalized treatment. ...
Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
... Meeting of the American Society of Clinical
oncology (ASCO) during an ASCO-sponsored press conference ... M.D., vice president, cancer research and global
oncology platform leader for Lilly.
Researchers ... Company
For more than four decades, Lilly
oncology has been dedicated to delivering innovative ...
Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer
... meeting of the American Society of Clinical
oncology (ASCO). The results of this study have also been ... science that is relevant and significant in
oncology today.
This study enrolled 439 patients with ... the study principal investigator, from Medical
oncology Service of the University Hospital 12 de Octubre, ...
Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
... -- The American Society of Clinical
oncology (ASCO) has selected new breast cancer research ... Zeina Nahleh, M.D., co-director of the Breast
oncology Multidisciplinary Team at Karmanos Cancer ... assistant professor of medicine in hematology and
oncology at Wayne State University School of Medicine. ...
FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)
... be presented at the American Society of Clinical
oncology 2009 annual meeting.
About CLL
CLL is ... under a collaboration between Genmab and the GSK
oncology and BioPharm R&D Units.
Ofatumumab is ... GlaxoSmithKline at www.gsk.com .
GSK
oncology is dedicated to producing innovations in cancer ...
Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
... at the 2009 American Society of Clinical
oncology (ASCO) Annual Meeting.
"We are excited to ... for high-risk neuroblastoma: Children's
oncology Group (COG) study ANBL0032
Lead investigator: A. L. Yu, Children's
oncology Group
Abstract 10067z, Oral ...
Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
... 5:00 p.m. ET) at the American Society of Clinical
oncology (ASCO) annual meeting in Orlando, demonstrated ... George Sledge, M.D., Ballve-Lantero Professor of
oncology at Indiana University in Indianapolis, and lead ... Highlight Application of Personalized Medicine in
oncology Setting
Additionally, Genomic Health, in ...
Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
... In Solid Tumors) in medical imaging-based
oncology trials. Perceptive Informatics, which actively ... #1881 during the American Society of Clinical
oncology (ASCO) Annual Meeting, being held today through ... use of medical imaging as a surrogate endpoint in
oncology trials.
"Independent review using RECIST is ...
New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer
... system.
John M. Maris, M.D., chief of
oncology at The Children's Hospital of Philadelphia, ... supervising the trial for the Children's
oncology Group, a cooperative organization that pools ... meeting of the American Society of Clinical
oncology (ASCO) in Orlando, Fla. In advance of the ...
Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
... a biopharmaceutical company focused on innovative
oncology therapies, today announced updated clinical data ... Cancer Network (NCCN) Practice Guidelines in
oncology (v.2.2009) after three months of therapy or ... development and commercialization of innovative
oncology products to impact the lives of people with ...
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
... that data on more than 15 compounds in its robust
oncology portfolio will be included at the 2009 American Society of Clinical
oncology (ASCO) annual meeting. These studies provide new ...
About the Novartis
oncology pipeline
The ...
PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
... milestone during the American Society of Clinical
oncology (ASCO) Annual Meeting, to be held May 29 - June ... in Orlando, Florida. PAREXEL's hematology and
oncology experts will be available during the ASCO meeting ... of improving the development success rate for
oncology drugs and getting treatments to patients sooner," ...
TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
... company that develops targeted therapies for
oncology and related diseases, announced today that Phase ... be presented at the American Society of Clinical
oncology annual meeting this May 28th and 29th in Orlando, ... cancer
Presenter: Lee Rosen, MD, Premiere
oncology - Los Angeles
Date and Time: Friday, May 29, ...
Mutant Genes in High-Risk Childhood Leukemias Identified
... Jude Children's Research Hospital, the Children's
oncology Group (COG), the University of New Mexico ... San Francisco ); Meenakshi Devidas (Children's
oncology Group); Susan Atlas, I-Ming Chen and Richard C. ... in part by a supplement to the Children's
oncology Group Chair's award; a National Cancer Institute ...
Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
... will present new data on the company's two lead
oncology compounds, BIBW 2992 and BIBF 1120 at the 2009 Annual Meeting of the American Society of Clinical
oncology (ASCO), the company announced today. Two studies ... Jonathan A. Ledermann, MD, Professor of Medical
oncology & Director at the Cancer Research UK & ...
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
... us closer to our goal of building a U.S.-based
oncology business," said Jerry McMahon, Ph.D., chairman ... be presented at the American Society of Clinical
oncology Annual Meeting, and the completion of patient ... Meeting of the American Society of Clinical
oncology (ASCO); the Company plans to hold an investor ...
Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
... to Hold Investor Event on Sunday, May 31 with
oncology Experts -
SOUTH SAN FRANCISCO, Calif., May ... Meeting of the American Society of Clinical
oncology (ASCO) in Orlando. The Company will present ... development and commercialization of innovative
oncology products to impact the lives of people with ...
Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
... Diagnostics to Mark Prometheus' Entry into
oncology Market; Rosetta to Receive Milestones and ... and are ideally suited to lead our entry into the
oncology market, while complementing our emerging internal
oncology diagnostics program."
"We believe that with ...
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
... toward our goal of developing picoplatin as an
oncology platform compound by advancing our pivotal Phase ... (CRPC) during the American Society of Clinical
oncology (ASCO) 2009 Genitourinary Cancers Symposium. ... Poniard announced an agreement with Baxter
oncology GmbH for the commercial manufacture and supply of ...
Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
... (OTC Bulletin Board: PVCT), a development-stage
oncology and dermatology biopharmaceutical company, ... at the 2009 American Society of Clinical
oncology (ASCO) Scientific Program on May 29 - June 2, ... on Melanoma and Other Cutaneous Malignancies , an
oncology CME-Certified Symposium , focused on therapeutic ...
SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
... calls for both the prospective gynecologic
oncology fellow and his/her institution to jointly submit ... year, and afford a greater number of gynecologic
oncology fellows interested in advanced training in breast ... offer this opportunity to interested gynecologic
oncology fellows and to be at the forefront of creating ...
Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
... I clinical trial and targeting B-cell related
oncology applications; a Btk inhibitor in advanced ... that treat serious unmet medical needs in
oncology and autoimmune diseases. Its deep and broad ...
ABOUT PACIFIC BIOPHARMA GROUP
PBG is an
oncology development company focused on development of ...
Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
... Amgen (Nasdaq: AMGN ), Millennium: The Takeda
oncology Company, and its parent company Takeda ... chief medical officer, Millennium: The Takeda
oncology Company. "We are pleased with the DMC ... Pharmaceutical Company and Millennium: The Takeda
oncology Company, motesanib is an investigational, highly ...
Society of Gynecologic Oncologists 40th Annual Meeting on Women's Cancer to Include Sessions on Robotics Surgery
... advances in the field of Gynecologic
oncology in the past few years. This minimally-invasive ... Dr. M. Patrick Lowe, Director of the Gynecologic
oncology Robotics and Minimally Invasive Surgery Program ... the next few years, the field of gynecologic
oncology will likely see widespread implementation of ...
Winning the War on Cancer: The Critical Role of Radiation Oncology
... Radiation
oncology Community Gathers with House Cancer Caucus on ... /PRNewswire-USNewswire/ -- A group of radiation
oncology providers, manufacturers and patient groups today ... in cancer research and breakthroughs in radiation
oncology are a very important part of this equation. With ...
St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment
... Children's Research Hospital and the Children's
oncology Group (COG) have discovered in children with ... please visit www.stjude.org .
Children's
oncology Group
The Children's
oncology Group/CureSearch ...
Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
... Article in Gynecologic
oncology Supports Use of Fujirebio Diagnostics'
HE4 Test ... January 2009 issue of the journal Gynecologic
oncology demonstrated the utility of combining Fujirebio ... Director of Medical Education, Program in Women's
oncology at Women and Infants' Hospital, and Assistant ...
RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
... profile of RAD001 has not yet been established in
oncology and there is no guarantee that RAD001 will become commercially available for
oncology indications. The active ingredient in RAD001 is ... that RAD001 will be approved for sale for any
oncology indication in any market. Nor can there be any ...
Gene Abnormality Found to Predict Childhood Leukemia Relapse
... therapies.
The findings of the Children's
oncology Group (COG) study, led by scientists from St. ... SP, Willman CL, Downing JR, and the Children's
oncology Group. Deletion of IKZF1 and Prognosis in Acute ... visit www.stjude.org .
The Children's
oncology Group/CureSearch
...
Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
... the Theros BCI is a valuable tool for helping
oncology medical
professionals and patients make ...
Advancing Molecular Diagnostics in
oncology
bioTheranostics discovers, develops and ... bioTheranostics
provides innovative tests to the
oncology community that drive personalized
treatment. The ...